FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

ULTRAtab Laboratories APAP 325 mg/Phenylephrine HCl Recall

APAP 325 mg/Phenylephrine HCl, 5mg Tablets Bulk Container, ULTRAtab Laboratories, Inc

ULTRAtab Laboratories, Inc. · Highland, NY

Risk level
Class II
Reported by FDA
Feb 16, 2022
Recall ID
D-0529-2022
Check your lot numberHow we source this data

Summary

ULTRAtab Laboratories recalled APAP 325 mg/Phenylephrine HCl starting Jan 26, 2022. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0529-2022 on Feb 16, 2022. Reason: CGMP Deviations. Status: Terminated.

Why it was recalled

CGMP Deviations

Product description

APAP 325 mg/Phenylephrine HCl, 5mg Tablets Bulk Container, ULTRAtab Laboratories, Inc., Highland, NY NDC 62959-135-00

Lot numbers, UPCs & expiration codes

Product Codes: C135LA Bulk Lots: 19F077

Where it was sold

Bulk product was distributed to 3 distributors who may have distributed finished product.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0529-2022
Classification
Class II
Status
Terminated
Recall initiated
Jan 26, 2022
FDA report date
Feb 16, 2022
Quantity
451,123 tablets
Recall type
Voluntary: Firm initiated
Recalling firm
ULTRAtab Laboratories, Inc.

Original FDA data

Every field from FDA enforcement report D-0529-2022, exactly as published.

Show all FDA fields
City
Highland
State
NY
Status
Terminated
Country
United States
Event ID
89334
Address
50 Toc Dr
Code information
Product Codes: C135LA Bulk Lots: 19F077
Postal code
12528-1506
Report date
Feb 16, 2022
Product type
Drugs
Recall number
D-0529-2022
Classification
Class II
Recalling firm
ULTRAtab Laboratories, Inc.
Product quantity
451,123 tablets
Termination date
Jan 7, 2025
Reason for recall
CGMP Deviations
Voluntary / mandated
Voluntary: Firm initiated
Product description
APAP 325 mg/Phenylephrine HCl, 5mg Tablets Bulk Container, ULTRAtab Laboratories, Inc., Highland, NY NDC 62959-135-00
Distribution pattern
Bulk product was distributed to 3 distributors who may have distributed finished product.
Recall initiation date
Jan 26, 2022
Initial firm notification
Letter
Center classification date
Feb 9, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0529-2022, published Feb 16, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls